YK-2168

• UNSPSC Description:

  YK-2168 is a differentiated selective inhibitor of CDK9[1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/yk-2168.html

• Smiles:

  ClC1=CN=C(NC(C2CCNCC2)=C3)C3=C1C4=CN(C)N=C4

• Molecular Weight:

  315.80

• References & Citations:

  [1]Yingchun Liu, et al. Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development. Bioorg Med Chem Lett. 2024 Nov 1:112:129941.Yingchun Liu, et al. Discovery and preclinical profile of YK-2168, a differentiated selective CDK9 inhibitor in clinical development. Bioorg Med Chem Lett. 2024 Nov 1:112:129941.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2571068-74-9